Related Experiment Video
Updated: Feb 4, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Defining antimicrobial resistance in cystic fibrosis
Timothy J Kidd1, Rafael Canton2, Miquel Ekkelenkamp3
1School of Chemistry and Molecular Biosciences, The University of Queensland, Lung Bacteria Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Abstract:
Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.
Insights
Antimicrobial resistance (AMR) poses unique challenges in cystic fibrosis (CF) lung infections, differing from acute infections. New diagnostic and treatment strategies are crucial for managing AMR in CF patients.
Area of Science:
- Medical Microbiology
- Pulmonology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) complicates treatment of chronic lung infections in cystic fibrosis (CF).
- AMR in CF exhibits distinct characteristics and clinical impacts compared to acute infections.
- Specialized diagnostic and therapeutic approaches are necessary for AMR in CF.
Purpose of the Study:
- To define antimicrobial resistance (AMR).
- To explain the mechanisms of AMR development.
- To review methods for measuring AMR and their limitations in the context of CF lung infections.
- To outline future research directions for AMR in CF.
Main Methods:
- Literature review of antimicrobial resistance in cystic fibrosis.
- Analysis of diagnostic methods for AMR.
- Discussion of clinical implications and treatment challenges.
Main Results:
- AMR in CF requires tailored diagnostic and treatment strategies.
- Current AMR measurement methods have limitations in CF.
- Understanding AMR mechanisms is key to effective management.
Conclusions:
- AMR is a critical issue in CF lung infections requiring distinct management.
- Further research and development are essential for novel AMR diagnostics and therapeutics in CF.
- A multidisciplinary approach is needed to combat AMR in CF.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defining Psychology
Piecewise-Defined Functions

